Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects

Neuropsychopharmacology

Volumn 22, Issue 5, 2000, Pages 480-492

  McCaul, Mary E ^a   Wand, Gary S ^a   Eissenberg, Thomas ^b   Rohde, Charles A ^c   Cheskin, Lawrence J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Alcoholism; Naltrexone; Opioid; Psychomotor responses; Subjective responses

Indexed keywords

NALTREXONE; PLACEBO;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUNKENNESS; FEMALE; HUMAN; MALE; MEMORY; NAUSEA; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SYMPTOMATOLOGY;

ADULT; ALCOHOL DRINKING; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PSYCHOMOTOR PERFORMANCE; TIME FACTORS;

EID: 0034061429     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00147-5     Document Type: Article

References (36)

1. Altshuler H.L., Phillips P.E., Feinhandler D.A. Alteration of ethanol self-administration by naltrexone. Life Sciences. 26:1980;679-688.
2. Bigelow G.E., Walsh S.L. Evaluation of potential pharmacotherapies. Response to cocaine challenge in the human laboratory Higgins S.T., Katz J.L. Cocaine Abuse. Behavior, Pharmacology, and Clinical Applications:1998;209-238 Academic Press, California.
3. Boyle A.E.L., Stewart R.B., Macenski M.J., Spiga R., Johnson B.A., Meisch R.A. Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys. Alcohol Clin Exp Res. 22:1998;359-366.
4. Croop R.S., Faulkner E.B., Labriola D.F., for The Naltrexone Usage Study Group The safety profile of naltrexone in the treatment of alcoholism. Archives General Psychiatry. 54:1997;1130-1135.
5. Czirr S.A., Hubbell C.L., Reid L.D. Daily water deprivation potentiates ethanol intake beyond a period of water intake. Alcohol. 4:1987;117-120.
6. Davidson D., Amit Z. Effect of ethanol drinking and naltrexone on subsequent drinking in rats. Alcohol. 14:1997;581-584.
7. Davidson D., Swift R., Fitz E. Naltrexone increases the latency to drink alcohol in social drinkers. Alcohol Clin Exp Res. 20:1996;732-739.
8. Doty P., de Wit H. Effects of naltrexone pretreatment on the subjective and performance effects of ethanol in social drinkers. Behav. Pharmacol. 6:1995;386-394.
9. Doty P., Kirk J.M., Cramblett M.J., de Wit H. Behavioral responses to ethanol in light and moderate social drinkers following naltrexone pretreatment. Drug and Alcohol Dependence. 47:1997;109-116.
10. Froehlich J.C., Harts J., Lumeng L., Li T.K. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacology, Biochemistry & Behavior. 35:1990;385-390.
11. Gianoulakis C. Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus. European Journal of Pharmacology. 180:1990;21-29.
12. Gianoulakis C., Krishnan B., Thavundayil J. Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Archives of General Psychiatry. 53:1996;250-257.
13. Haertzen C.A. An overview of Addiction Research Center Inventory scales (ARCI). An appendix and manual of scales. Vol. DHEW Publication No. (ADM) 74-92:1974;Rockville, MD, National Institute on Drug Abuse.
14. Hubbell C.L., Czirr S.A., Hunter G.A., Beaman C.M., LeCann N.C., Reid L.D. Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol. 3:1986;39-54.
15. Hubbell C.L., Marglin S.H., Spitalnic S.J., Abelson M.L., Wild K.D., Reid L.D. Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage. Alcohol. 8:1991;355-367.
16. Hyytia P., Sinclair J.D. Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcohol Exp Clin Res. 17:1993;631-636.
17. King A.C., Volpicelli J.R., Frazer A., O'Brien C.P. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology. 129:1997;15-22.
18. Krishnan-Sarin S., Portoghese P.S., Li T.K., Froehlich J.C. The delta opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacology, Biochemistry & Behavior. 52:1995;153-159.
19. Li X.W., Li T.K., Froehlich J.C. Alcohol alters preproenkephalin mRNA content in the shell and core of the nucleus accumbens. Alcoholism: Clinical and Experimental Research. 20:1996;53.
20. McCaul M.E., Turkkan J.S., Svikis D.S., Bigelow G.E. Alcohol and secobarbital effects as a function of familial alcoholism. Acute psychophysiological effects Alcoholism: Clinical and Experimental Research. 14:1990;704-712.
21. McLeod D.R., Griffiths R.R., Bigelow G.E., Yingling J. An automated version of the digit symbol substitution task (DSST). Behavior Research, Methods & Instrumentation. 14:1982;463-466.
22. Myers R.D., Borg S., Mossberg R. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol. 3:1986;383-388.
23. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Archives of General Psychiatry. 49:1992;881-887.
24. O'Malley S.S., Jaffe A.J., Rode S., Rounsaville B.J. Experience of a "slip" among alcoholics treated with naltrexone or placebo. American Journal of Psychiatry. 153:1996;281-283.
25. Phillips T.J., Wenger C.D., Dorow J.D. Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice. Alcohol Clin Exp Res. 21:1997;691-702.
26. Reid L.D., Delconte J.D., Nichols M.L., Bilsky E.J., Hubbell C.L. Tests of opioid deficiency hypotheses of alcoholism. Alcohol. 8:1991;247-257.
27. Reid L.D., Gardell L.R., Chattopadhyay S., Hubbell C.L. Periodic naltrexone and propensity to take alcoholic beverage. Alcohol Clin Exp Res. 20:1996;1329-1334.
28. Schuckit M.A. Self-rating of alcohol intoxication by young men with and without family histories of alcoholism. Journal of Studies on Alcohol. 41:1980;242-249.
29. Selzer M.L. The Michigan Alcoholism Screening Test. The quest for a new diagnostic instrument American Journal of Psychiatry. 127:1971;1653-1658.
30. Spitzer R.L., Williams J.B.W. Structured Interview for DSM-IIIR (SCID). 1987;Biometrics Research, New York, New York State Psychiatric Institute.
31. Swift R.M., Whelihan W., Kuznetsov O. Naltrexone-induced alterations in human ethanol intoxication. American Journal of Psychiatry. 151:1994;1463-1467.
32. Volpicelli J., David M.A., Olgin J.E. Naltrexone blocks the post-shock increase of ethanol consumption. Life Sciences. 38:1986;841-847.
33. Volpicelli J.R., Alterman A.I., Hayashida M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry. 49:1992;876-880.
34. Volpicelli J.R., Watson N.T., King A., Sherman C.E., O'Brien C.P. Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry. 152:1995;613-615.
35. Wand G.S., Mangold D., El Diery S., McCaul M.E., Hoover D. Offspring from families with a high density of alcohol dependent individuals have altered endogenous brain opioidergic activity. Archives of General Psychiatry. 55:1998;1114-1119.
36. Weiss F., Mitchiner M., Bloom F.E., Koob G.F. Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology. 101:1990;178-186.